Effects of raloxifene on adipocytokines in Japanese osteoporotic postmenopausal women with and without type 2 diabetes

Horm Metab Res. 2006 Feb;38(2):130-3. doi: 10.1055/s-2006-925140.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adipose Tissue / metabolism*
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Body Fat Distribution / methods
  • Bone Density Conservation Agents / administration & dosage*
  • Cytokines / blood*
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Female
  • Humans
  • Inflammation / blood
  • Inflammation / complications
  • Inflammation / drug therapy
  • Japan
  • Osteoporosis, Postmenopausal / blood*
  • Osteoporosis, Postmenopausal / complications
  • Osteoporosis, Postmenopausal / prevention & control
  • Raloxifene Hydrochloride / administration & dosage*

Substances

  • Biomarkers
  • Bone Density Conservation Agents
  • Cytokines
  • Raloxifene Hydrochloride